Live Breaking News & Updates on Eagle Pharmaceuticals Stock
Stay updated with breaking news from Eagle pharmaceuticals stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investment analysts at StockNews.com started coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Up 2.5 % EGRX opened at $3.43 on Wednesday. The company’s 50-day moving […] ....
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $7.47 and traded as low as $4.57. Eagle Pharmaceuticals shares last traded at $4.69, with a volume of 161,336 shares changing hands. Eagle Pharmaceuticals Stock Up 2.1 […] ....
Brandes Investment Partners LP boosted its holdings in shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Free Report) by 34.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,134,363 shares of the specialty pharmaceutical company’s stock after buying an additional 293,276 shares during the period. […] ....
Brandes Investment Partners LP grew its position in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Free Report) by 34.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,134,363 shares of the specialty pharmaceutical company’s stock after buying an additional 293,276 shares […] ....
02.01.2024 - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) between August 8, 2023 and November 28, 2023, both dates . ....